DSS Inc

Aktienanalyse zu DSS Inc (DSS)

$0.610

+0.006 (+1.04%)Zum Schluss

Loading chart…
Hoch
0.614
Eröffnung
0.604
Volumengewichteter Durchschnittskurs
0.61
Volumen
3.65K
Marktkap.
12.39M
Tief
0.604
Umsatz
2.22K
EV/EBITDA, TTM
0.00

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.

www.dssworld.com

KI-Analyse of DSS Inc (DSS)

Verkaufen

DSS Inc is not a good buy right now due to significant financial losses and negative trends. The current price is $0.61, and the company has a forward P/E ratio of 0, indicating a lack of earnings potential. Additionally, the gross margin is negative at -25.39%, which reflects ongoing profitability issues. The main risk is the high debt-to-equity ratio of 439.61%, indicating potential solvency concerns.

Bewertungskennzahlen

Das aktuelle erwartete KGV von DSS Inc (DSS) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von -1.44.

Erwartetes KGV

Überbewertet
5J-Durchschnitt P/E
-1.44
Aktuelles P/E
0.00
Überbewertet
-0.57
Unterbewertet
-2.30

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
-5.86
Aktuelles EV/EBITDA
0.00
Überbewertet
1.05
Unterbewertet
-12.76

Erwartetes KUV

Unterbewertet
5J-Durchschnitt P/S
0.66
Aktuelles P/S
0.00
Überbewertet
1.07
Unterbewertet
0.25

Alphio-AI-Kursszenarien für DSS

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%DSS

$0.63

Szenariopreis

B

Basis

Basis · 50%DSS

$0.63

Szenariopreis

B

Bärisch

Bärisch · 25%DSS

$0.61

Szenariopreis

Event-Zeitleiste

2026-09-04 (ET)

09:00:00

DSS, Inc. Cancels Proposed Public Offering

2026-09-03 (ET)

21:00:00

DSS Commences Public Offering of Common Stock

2026-05-08 (ET)

17:10:00

DSS Annual Report Contains Going Concern Audit Opinion

2026-02-04 (ET)

08:40:00

DSS Prices Public Offering Expected to Raise $1M

2026-02-03 (ET)

20:30:00

Aegis Capital Acts as Sole Underwriter for Offering

News

DSS FAQ – beantwortet von Alphio AI

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing. It operates in the Basic Materials sector (PAPERBOARD CONTAINERS & BOXES industry).

DSS Inc is not a good buy right now due to significant financial losses and negative trends. The current price is $0.61, and the company has a forward P/E ratio of 0, indicating a lack of earnings potential. Additionally, the gross margin is negative at -25.39%, which reflects ongoing profitability issues. The main risk is the high debt-to-equity ratio of 439.61%, indicating potential solvency concerns.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln